A Review to Summarize the Available Evidences on Turmeric's (Curcuma Longa) Medicinal Properties to Understand the Scope of Its Efficacy in the Treatment and Prevention of Covid19 Diseases.

Abstract

The massive outbreak of coronavirus disease (COVID-19) across the world, has affected more than 200 countries and territories which was originated in bats and transmitted to humans through unknown intermediate hosts in the Wuhan seafood market, China, in December of 2019. Most people infected with the COVID-19 virus experience mild to moderate respiratory illness and recover without requiring special treatment. Older people, and those with underlying medical problems like cardiovascular disease, diabetes, chronic respiratory disease, and cancer are more likely to develop serious illness. However, few broad-spectrum antiviral drugs have been evaluated against COVID-19 in clinical trials, resulted in clinical recovery. There is no system of medicine has any evidence-based treatment for COVID-19 yet and vaccine is recommended. WHO is helping to accelerate drug research. In India, Ministry of Ayush has issued guidelines which contain preventive and remedial information and advisories for the management of COVID19 symptoms. This review has assembled evidences of Turmeric/Curcuma longa which is one of the ingredient of the ayurvedic preventive majors issued by Ministry of Ayush and revealed various routes of administration of Turmeric /Curcuma longa asserted in Ayurvedic Texts as a remedy and additional preventive majors for COVID 19 symptoms.